Eileen J Brantley (Eileen Brantley)

Years Active: 2018-2023
Publications (10 Years): 4

Loma Linda University School of Medicine

Meharry Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Loma Linda University School of Medicine Jul 01 2004

United States

Assistant Professor :: Basic Sciences

Education History

Meharry Medical College

United States

PHD :: Pharmacology

Publications

Jonathan Wooten, Nicole Mavingire, Katherine Damar, Andrea L Perez, Eileen J Brantley
Triumphs and challenges in exploiting poly(ADP-ribose) polymerase inhibition to combat triple-negative breast cancer. Journal of cellular physiology (2023)
Nicole Mavingire, Petreena Campbell, Tiantian Liu, Jonathan Wooten, Salma Khan, Xin Chen, Jason Matthews, Charles Wang, Eileen J Brantley
Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties. Precision clinical medicine 5 (2) (2022)
Petreena S Campbell, Nicole Mavingire, Salma Khan, Leah K Rowland, Jonathan V Wooten, Anna Opoku-Agyeman, Ashley Guevara, Ubaldo Soto, Fiorella Cavalli, Andrea Irene Loaiza-Pérez, Gayathri Nagaraj, Laura J Denham, Olayemi Adeoye, Brittany D Jenkins, Melissa B Davis, Rachel Schiff, Eileen J Brantley
AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells. Journal of cellular physiology 234 (1) (2018)
Leah K Rowland, Petreena S Campbell, Nicole Mavingire, Jonathan V Wooten, Lancelot McLean, Dain Zylstra, Gabriell Thorne, Devin Daly, Kristopher Boyle, Sonya Whang, Juli Unternaehrer, Eileen J Brantley
Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death. Journal of cellular biochemistry 120 (4) (2018)

Eileen J Brantley.css-eqlu8i{font-size:small;padding-left:4px;} (Eileen Brantley)